Cargando…
Combined intracavitary thermotherapy with iron oxide nanoparticles and radiotherapy as local treatment modality in recurrent glioblastoma patients
BACKGROUND: There is an increasing interest in local tumor ablative treatment modalities that induce immunogenic cell death and the generation of antitumor immune responses. METHODS: We report six recurrent glioblastoma patients who were treated with intracavitary thermotherapy after coating the res...
Autores principales: | Grauer, Oliver, Jaber, Mohammed, Hess, Katharina, Weckesser, Matthias, Schwindt, Wolfram, Maring, Stephan, Wölfer, Johannes, Stummer, Walter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341053/ https://www.ncbi.nlm.nih.gov/pubmed/30506500 http://dx.doi.org/10.1007/s11060-018-03005-x |
Ejemplares similares
-
Combined Fluorescence-Guided Resection and Intracavitary Thermotherapy with Superparamagnetic Iron-Oxide Nanoparticles for Recurrent High-Grade Glioma: Case Series with Emphasis on Complication Management
por: Schwake, Michael, et al.
Publicado: (2022) -
5-Aminolevulinic Acid Fluorescence-Guided Resection of (18)F-FET-PET Positive Tumor Beyond Gadolinium Enhancing Tumor Improves Survival in Glioblastoma
por: Müther, Michael, et al.
Publicado: (2019) -
The Value of 5-Aminolevulinic Acid in Low-grade Gliomas and High-grade Gliomas Lacking Glioblastoma Imaging Features: An Analysis Based on Fluorescence, Magnetic Resonance Imaging, (18)F-Fluoroethyl Tyrosine Positron Emission Tomography, and Tumor Molecular Factors
por: Jaber, Mohammed, et al.
Publicado: (2015) -
Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme
por: Maier-Hauff, Klaus, et al.
Publicado: (2010) -
Is Visible Aminolevulinic Acid-Induced Fluorescence an Independent Biomarker for Prognosis in Histologically Confirmed (World Health Organization 2016) Low-Grade Gliomas?
por: Jaber, Mohammed, et al.
Publicado: (2019)